Background
==========

Fish are highly nutritious components of the human diet. In addition to providing high quality and easily digested protein, vitamins and minerals, they are particularly important in being the main source of essential n-3 long-chain polyunsaturated fatty acids (LC-PUFA). The beneficial effects of these fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), include prevention of a range of cardiovascular and inflammatory diseases, and neurological disorders \[[@B1]\]. With catches from commercial fisheries stagnating since 2001, aquaculture is supplying an increasing proportion of fish for human consumption, estimated at around 50% of total supply in 2008 \[[@B2]\]. However, the expansion of aquaculture and the demands it makes upon resources provide many challenges, leading to questions concerning the sustainability of this activity. In particular, marine and salmonid aquaculture relies heavily on fish meal (FM) and fish oil (FO), obtained from wild fishery stocks, for the production of fish feeds and around 88.5% of the total global production of FO is currently used by aquaculture \[[@B3]\]. The increasing scarcity of FO supplies will seriously limit aquaculture growth, and the future of this activity therefore strongly depends on reducing its reliance on FO by seeking to replace them with alternative, largely terrestrial, oils. Vegetable oils (VO) represent a potentially critical resource in this respect. However, VO lack the n-3 LC-PUFA which are abundant in FO, and farming fish on diets containing a high proportion of VO results in lower levels of these omega-3 fatty acids in flesh, compromising their health-promoting effects to the human consumer \[[@B4]\].

The use of selective breeding programs to enhance traits of commercial importance is becoming increasingly more common in aquaculture \[[@B5]\]. Combining genetic selection with changes in commercial feed formulations (i.e., higher levels of inclusion of VO) may be a viable strategy to meet worldwide demand for farmed fish without compromising animal welfare or nutritional value. Recently we showed that deposition and/or retention in flesh of dietary n-3 LC-PUFA, EPA and DHA, is a highly heritable trait in salmon \[[@B6]\], prompting further interest in exploring genotype-nutrient interactions. Other recent work has investigated potential interactions between genetic selection for body fatness and dietary lipid level in rainbow trout \[[@B7],[@B8]\], and the effects of FM and/or FO replacement on the liver transcriptome of both rainbow trout and Atlantic salmon \[[@B9]-[@B11]\]. However, there are few data on the interaction between genotype and dietary fatty acid composition. In this respect, microarrays have great potential for application as hypothesis-generating tools. The objective of the present study was to investigate nutrient-genotype interactions in two groups of Atlantic salmon families, Lean and Fat, fed diets where FO was completely replaced by a VO blend. The knowledge gained concerning how this substitution affects hepatic metabolism and, furthermore, how these effects may depend on the genetic background of the fish, not only informs our understanding of lipid metabolism more generally but is also highly relevant to the strategy of genetic selection for families better adapted to alternative and more sustainable feed formulations in the future. A previous study has already focused on hepatic cholesterol and lipoprotein metabolism \[[@B12]\], which was shown to present a significant diet × genotype interaction, while here we will present more broadly the effects of the factors \'diet\' and \'genotype\'.

Results
=======

Microarray results
------------------

Two-way ANOVA of the cDNA microarray dataset returned a high number of features showing evidence of differential expression for each factor - 713 for diet and 788 for genotype - and hence a more detailed analysis was restricted to the top 100 most significant hits for each factor, which were then categorised according to function (excluding 33-35% non-annotated features) (Figure [1](#F1){ref-type="fig"}). The functional category most affected by diet was that of metabolism (mainly lipid and carbohydrate metabolism), while immune response and intracellular trafficking were also affected. Within lipid metabolism, the affected genes are involved in PUFA, fatty acid and cholesterol biosynthesis (fatty acyl desaturases - Δ5 fad and Δ6 fad, fatty acid synthase - FAS, squalene monooxygenase and possibly cytochrome P450 reductase), glycerophospholipid metabolism (phospholipase D3) and acylglycerol homeostasis (angiopoietin-like 3). Some genes related to carbohydrate metabolism, implicated in glycolysis, glutamine/fructose 6-phosphate and glycerol-3-phosphate metabolism, such as alpha-enolase, glutamine-fructose-6-phosphate transaminase 1(GFPT1) and glycerol kinase, respectively, were also identified as being significantly affected by diet. Genotype had a lower impact on metabolism-related genes (primarily lipid and protein metabolism) and affected mostly genes involved in signalling. Regarding lipid metabolism, primary roles of affected genes are in glycerophospholipid metabolism (N-acylethanolamine-hydrolyzing acid amidase precursor, lipid phosphate phosphohydrolase 2 - LPP2 and 1-acyl-sn-glycerol-3-phosphate acyltransferase - AGPAT), fatty acid transport (intestinal fatty acid binding protein) and lipoprotein metabolism (apolipoprotein B - ApoB and endothelial lipase - EL). In addition, both factors had an effect on a relatively high number of transcription-related genes. Detailed lists of the top 100 most significant genes for diet and genotype, organised by biological function and including the normalised expression ratio between treatments, are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively. Gene Ontology enrichment analysis, which enables the identification of GO terms significantly enriched in the input entity list when compared to the whole array dataset, was performed for both factors, providing evidence for which biological processes may be particularly altered in the experimental conditions being compared. For diet, seven significant GO terms, all interrelated, were identified: oxidoreductase activity, stearoyl-CoA 9-desaturase activity, unsaturated fatty acid biosynthetic and metabolic processes, very long chain fatty acid (VLCFA) biosynthetic and metabolic processes. This is explained by the high number of Δ5 fad and Δ6 fad features that were significantly altered when dietary FO was replaced by VO (Table [1](#T1){ref-type="table"}). In contrast, no GO terms were significantly enriched in the genotype list.

![**Functional categories of genes differentially expressed in Atlantic salmon liver**. The top 100 most significant clones (two-way ANOVA analysis; p \< 0.05) which were differentially expressed between the two diets (A) and family groups (B) were categorized according to biological function. Non-annotated clones, those representing the same gene or with a miscellaneous function (Tables 2 and 3) are not represented.](1471-2164-12-255-1){#F1}

###### 

Liver transcripts corresponding to the top 100 most significant features exhibiting differential expression between diets

  Accession or probe number                   Gene                                                                    VO/FO    ANOVA p-value   
  ------------------------------------------- ----------------------------------------------------------------------- -------- --------------- ----------
  ***Metabolism***                                                                                                                             
  *Lipid metabolism*                                                                                                                           
  can_D6D_S1B04                               Delta-6 fatty acyl desaturase                                           2.8      1.9             \<0.0001
  can_D6D_S1B03                               Delta-6 fatty acyl desaturase                                           2.1      1.4             \<0.0001
  can_D5D_S1B01                               Delta-5 fatty acyl desaturase                                           2.3      1.5             \<0.0001
  can_D6O_S1B06                               Delta-6 fatty acyl desaturase                                           2.0      1.4             \<0.0001
  CK887422                                    Delta-6 fatty acyl desaturase                                           2.0      1.8             \<0.0001
  EG647320                                    Delta-6 fatty acyl desaturase                                           1.8      1.4             0.0001
  CK876943                                    Fatty acid synthase                                                     1.4      1.6             0.0002
  can_D5D_S1B02                               Delta-5 fatty acyl desaturase                                           2.1      1.2             0.0003
  CK894344                                    Phospholipase D3                                                        \- 1.1   \- 1.2          0.0006
  EG647463                                    Cytochrome P450 reductase                                               \- 1.4   \- 1.1          0.0017
  liv_lrr_01F07                               Angiopoietin-like 3                                                     1.2      1.4             0.0020
  can_D5O_S1B05                               Delta-6 fatty acyl desaturase                                           1.5      1.2             0.0045
  CK879648                                    Squalene monooxygenase                                                  1.9      1.1             0.0058
  *Protein and amino acid metabolism*                                                                                                          
  CK893821                                    Sequestosome 1or ubiquitin-binding protein P62                          \- 1.3   \- 1.1          0.0022
  CK884400                                    Kynureninase (L-kynurenine hydrolase)                                   1.3      1.2             0.0065
  *Carbohydrate metabolism*                                                                                                                    
  int_oss_T4F08                               Alpha-enolase putative                                                  \- 1.2   \- 1.0          0.0007
  liv_lrr_01A06                               Glutamine-fructose-6-phosphate transaminase 1                           1.2      1.8             0.0032
  CO470771                                    Glycerol kinase                                                         1.1      1.1             0.0062
  *Xenobiotic and oxidant metabolism*                                                                                                          
  AJ425332                                    Thioredoxin domain-containing protein 8                                 \- 1.3   \- 1.3          0.0024
  EG355339                                    Glutathione S-transferase A                                             \- 1.4   \- 1.4          0.0036
  ***Transport/intracellular trafficking***                                                                                                    
  CK886667                                    Na/K ATPase                                                             1.5      1.1             \<0.0001
  CN181143                                    Coatomer subunit alpha                                                  1.2      1.4             0.0004
  DW588711                                    Synaptic vesicle glycoprotein 2B                                        1.1      1.1             0.0004
  CK894482                                    Taurine transporter                                                     \- 1.3   \- 1.3          0.0019
  CK887866                                    ABC-type branched-chain amino acid transport systems ATPase component   1.2      1.1             0.0022
  CO470399                                    Sodium/potassium-transporting                                           \- 1.2   \- 1.2          0.0044
  EG647422                                    Transferrin                                                             \- 1.2   \- 1.1          0.0047
  EG648286                                    ATP-binding cassette sub-family B member 10, mitochondrial              1.2      1.3             0.0055
  AM083913                                    Chromatin modifying protein 2a                                          \- 1.3   \- 1.2          0.0068
  ***Regulation of transcription***                                                                                                            
  CK894063                                    Zinc finger protein 183                                                 \- 1.5   \- 1.3          0.0003
  CK890154                                    Butyrate response factor 2                                              1.5      1.1             0.0043
  EG648112                                    Retrovirus-related Pol polyprotein                                      1.1      1.3             0.0046
  CK885196                                    CCAAT/enhancer binding protein delta1                                   1.2      1.2             0.0052
  CK890573                                    MADS box protein AP1b                                                   1.2      1.2             0.0053
  CK883722                                    Y-box binding protein                                                   1.1      1.3             0.0067
  ***Translation***                                                                                                                            
  AM402452                                    Phenylalanyl-tRNA synthetase, alpha subunit                             1.4      1.9             0.0022
  ***Signalling/Signal transduction***                                                                                                         
  CK886572                                    GSK-3-binding protein                                                   1.9      1.0             0.0002
  CK892148                                    Growth factor receptor-bound protein 7                                  \- 1.5   \- 1.1          0.0028
  ova_opk_09K06                               Phosphoinositide 3-protein kinase                                       \- 1.1   \- 1.3          0.0031
  CK873849                                    Receptor-type tyrosine-protein phosphatase beta precursor               \- 1.1   \- 1.1          0.0036
  DW590775                                    Myozenin-1                                                              1.6      1.5             0.0055
  ***Immune response***                                                                                                                        
  EG647383                                    Human leukocyte antigen (HLA) class II histocompatibility               1.1      1.2             0.0008
  AM402762                                    Complement component C8 alpha chain                                     1.3      1.7             0.0018
  EG649410                                    D-dopachrome tautomerase                                                1.4      1.1             0.0019
  AJ425750                                    Non-histone chromosomal protein H6                                      1.1      1.3             0.0024
  CK884265                                    Ganglioside GM2 activator                                               1.3      1.1             0.0030
  AM402841                                    Complement component C8 alpha chain                                     1.5      2.1             0.0032
  CK886548                                    T cell receptor (TCR)-alpha/delta locus                                 \- 1.2   \- 1.0          0.0041
  spl_sts_18A08                               Leukotriene B4 receptor 1 putative                                      \- 1.4   \- 1.1          0.0047
  CK880083                                    Interleukin-15 precursor                                                1.1      1.3             0.0067
  AJ425732                                    CD97 antigen isoform 2                                                  1.2      1.1             0.0066
  ***Miscellaneous and unknown function***                                                                                                     
  CK897269                                    Biotinidase precursor                                                   1.3      1.7             0.0002
  AM402518                                    Biotinidase                                                             1.4      1.9             0.0006
  CK894173                                    EFHD2 (EF hand domain containing2)                                      1.2      1.1             0.0007
  kid_cki_A1E04                               S100-A1 calcium binding                                                 1.4      1.1             0.0009
  CO469646                                    beta B3-crystallin                                                      \- 1.1   \- 1.0          0.0012
  CO469710                                    Transmembrane protein 30A                                               \- 1.1   \- 1.2          0.0019
  AJ425502                                    Heme oxygenase 1                                                        \- 2.7   \- 1.7          0.0024
  CK885237                                    EF-hand domain-containing protein D2                                    1.1      1.1             0.0026
  AJ425502                                    Heme oxygenase 1                                                        \- 2.6   \- 1.4          0.0037
  DW588567                                    S100 calcium binding protein beta subunit                               1.1      1.1             0.0042
  CK897725                                    Type-1 growth hormone                                                   1.1      1.1             0.0053
  BM414485                                    Apoptosis-inducing factor mitochondrion-associated inducer              1.5      1.4             0.0054
  BM414504                                    Syndecan 2                                                              \- 1.2   \- 1.1          0.0061
  BI468143                                    Anaphase-promoting complex subunit CDC26                                \- 1.3   \- 1.3          0.0064
  CK885116                                    17-beta hydroxysteroid dehydrogenase 13                                 \- 1.1   \- 1.4          0.0065

Annotated features (65% of all clones) are arranged by categories of biological function and, within these, by decreasing significance (assessed by two-way ANOVA). Also indicated are the GenBank accession numbers for each clone (or, when not available, the probe number is given instead) and the expression ratio between fish fed VO and those fed FO, for each genotype (Lean and Fat).

###### 

Liver transcripts corresponding to the top 100 most significant features exhibiting differential expression between family groups

  Accession or probe number                                 Gene                                                         Lean/Fat   ANOVA p-value   
  --------------------------------------------------------- ------------------------------------------------------------ ---------- --------------- ----------
  ***Metabolism***                                                                                                                                  
  *Lipid metabolism*                                                                                                                                
  CK889835                                                  N-acylethanolamine-hydrolyzing acid amidase precursor        \- 1.4     \- 1.2          0.0001
  can_Apo_S1A12                                             Apolipoprotein B                                             \- 1.4     \- 1.1          0.0014
  BM414066                                                  Endothelial lipase precursor                                 \- 1.1     \- 1.6          0.0015
  CK898924                                                  Lipid phosphate phosphohydrolase 2                           \- 1.2     \- 1.2          0.0017
  AJ425826                                                  Intestinal fatty acid binding protein                        1.1        1.2             0.0032
  CO470953                                                  1-acyl-sn-glycerol-3-phosphate acyltransferase               \- 1.1     \- 1.3          0.0040
  *Energy metabolism/generation of precursor metabolites*                                                                                           
  EG649459                                                  NADH dehydrogenase (ubiquinone) 1 beta subcomplex            1.2        1.2             0.0009
  *Protein and amino acid metabolism*                                                                                                               
  CK900470                                                  26S protease regulatory subunit 7                            \- 1.1     \- 1.2          0.0020
  mus_mfo_15B08                                             Proteasome subunit alpha type-1                              1.2        1.1             0.0021
  EG648604                                                  Serine protease-like protein                                 1.0        1.4             0.0023
  CO470297                                                  Transmembrane protease, serine 2                             \- 1.2     \- 1.1          0.0032
  DW592216                                                  Ubiquitin carboxyl-terminal hydrolase 5                      \- 1.1     \- 1.1          0.0040
  ***Transport/intracellular trafficking***                                                                                                         
  CK886667                                                  Na/K ATPase                                                  1.1        1.6             \<0.0001
  CK884193                                                  Polycystin-2 (Polycystic kidney disease 2 protein homolog)   1.1        1.2             0.0002
  CK890974                                                  Mitochondrial solute carrier family 25 member 25             \- 1.2     \- 2.2          0.0002
  CK896189                                                  Mitochondrial solute carrier family 25 member 25             \- 1.3     \- 2.3          0.0002
  CK880187                                                  ATP-binding cassette sub-family B member 8, mitochondrial    \- 1.3     \- 1.1          0.0011
  ***Regulation of transcription***                                                                                                                 
  CK881770                                                  Hematopoietically-expressed homeobox protein                 \- 1.1     \- 1.6          0.0001
  CK888834                                                  BTEB transcription factor                                    \- 1.4     \- 1.5          0.0002
  CK895950                                                  Transcription factor CP2-like                                \- 1.2     \- 1.6          0.0010
  CK884953                                                  Nuclear transcription factor Y subunit beta                  \- 1.2     \- 1.1          0.0015
  CK888548                                                  Rev protein - Human immunodeficiency virus 1                 \- 1.5     \- 1.0          0.0019
  CK883410                                                  Retinoic acid receptor gamma (nuclear receptor)              \- 1.1     \- 1.1          0.0020
  int_rpk_78B12                                             Sp3 transcription factor                                     \- 1.1     \- 1.4          0.0035
  CK876044                                                  Homeobox protein HoxB13                                      \- 1.2     \- 1.2          0.0041
  DW589427                                                  Cullin-associated and neddylation-dissociated 1 (CAND1)      1.4        1.1             0.0044
  ***Translation***                                                                                                                                 
  AJ424434                                                  Ribosome production factor 1                                 1.1        1.2             0.0002
  gil_oss_G6P11                                             40S ribosomal protein S23                                    1.3        1.3             0.0008
  EG648403                                                  60S ribosomal protein L7a                                    1.2        1.2             0.0013
  CK893177                                                  40S ribosomal protein S26                                    1.1        1.2             0.0013
  DW591137                                                  40S ribosomal protein S3a                                    \- 1.2     \- 1.1          0.0024
  EG647811                                                  60S ribosomal protein L7                                     1.1        1.1             0.0026
  EG648956                                                  Eukaryotic translation initiation factor 1A                  1.1        1.1             0.0033
  AJ424851                                                  40S ribosomal protein S18                                    1.2        1.2             0.0034
  ***Signalling/Signal transduction***                                                                                                              
  CK884714                                                  14-3-3 protein epsilon                                       1.1        1.1             0.0003
  EG648400                                                  Guanine nucleotide binding protein (G protein)               \- 1.2     \- 1.2          0.0004
  CK888542                                                  Insulin-like growth factor binding protein 1                 \- 1.2     \- 2.5          0.0008
  CK886572                                                  GSK-3-binding protein putative                               \- 1.1     1.8             0.0009
  CK877143                                                  Calpain-1                                                    \- 1.1     \- 1.4          0.0010
  EG648399                                                  PTC7 protein phosphatase homolog                             \- 1.2     \- 1.1          0.0016
  EG648333                                                  Stathmin                                                     1.1        1.2             0.0018
  CK898969                                                  G-protein coupled receptor 37                                \- 1.1     \- 1.1          0.0019
  DW589782                                                  Amyloid beta (A4) precursor-like protein                     1.1        1.2             0.0034
  CK898590                                                  Mitogen-activated protein kinase kinase 4                    \- 1.0     \- 1.2          0.0035
  CK897997                                                  Calpastatin                                                  \- 1.1     \- 1.1          0.0039
  AJ424385                                                  Protein tyrosine phosphatase, receptor-type, zeta1           \- 1.1     \- 1.2          0.0041
  ***Structural proteins***                                                                                                                         
  AJ425204                                                  Tropomyosin-1 alpha (muscle contraction)                     \- 1.1     \- 1.2          0.0031
  ***Immune response***                                                                                                                             
  CK886548                                                  T cell receptor (TCR)-alpha/delta locus                      \- 1.1     \- 1.2          0.0005
  CK894741                                                  Complement factor D (adapsin)                                \- 1.1     \- 1.2          0.0007
  AM042439                                                  Major histocompatibility complex (MHC) class I antigene      \- 1.3     \- 1.4          0.0014
  kid_cki_A1G02                                             Interferon-inducible protein                                 \- 1.2     \- 1.4          0.0015
  CO471904                                                  Major histocompatability complex (MHCI)                      \- 1.1     \- 1.2          0.0019
  CK894557                                                  Major histocompatability complex (MHCI)                      \- 1.2     \- 1.1          0.0023
  AM042249                                                  Major histocompatability complex (MHCI)                      \- 1.1     \- 1.2          0.0025
  bra_opk_01B08                                             Scavenger receptor cysteine-rich gene                        \- 1.3     \- 1.6          0.0029
  CO469739                                                  T-cell receptor(TCR)-alpha/delta locus                       \- 1.1     \- 1.1          0.0030
  AJ424124                                                  Major histocompatibility complex (MHC class I)               \- 1.2     \- 1.1          0.0037
  hrt_opk_07E23                                             Interferon alpha 1-like                                      \- 1.1     \- 1.1          0.0041
  ***Miscellaneous and unknown function***                                                                                                          
  CK898014                                                  Protein fuzzy homolog                                        \- 1.1     \- 1.2          0.0002
  kid_cki_A2A05                                             Cyclin B2                                                    \- 1.3     \- 1.4          0.0006
  EG647643                                                  Purine nucleoside phosphorylase                              \- 1.1     \- 2.0          0.0010
  liv_lrr_07B04                                             Nuclear protein 1                                            \- 1.1     \- 2.1          0.0028
  AM402622                                                  Non-POU domain containing, octamer-binding                   \- 1.7     \- 1.4          0.0029
  EG648147                                                  Adhesion-regulating molecule 1                               \- 1.2     \- 1.1          0.0037
  BM414485                                                  Apoptosis-inducing factor mitochondrion-associated inducer   1.4        1.5             0.0038
  DW589496                                                  Cyclin-dependent kinase inhibitor                            \- 1.2     \- 1.3          0.0044

Annotated features (67% of all clones) are arranged by categories of biological function and, within these, by decreasing significance (assessed by two-way ANOVA). Also indicated are the GenBank accession numbers for each clone (or, when not available, the probe number is given instead) and the expression ratio between Lean and Fat fish fed either FO or VO.

RT-qPCR
-------

Quantification of gene expression by RT-qPCR was performed to partially validate the microarray results and to examine particular genes of interest in detail. The latter included several fatty acyl desaturase and elongase genes involved in the LC-PUFA biosynthesis pathway that were identified by GO analysis as being significantly affected by diet, as well as peroxisome proliferator-activated receptors (PPAR) and sterol regulatory element binding protein 1 (SREBP-1), which have important roles in regulating the expression of multiple lipid metabolism genes (Table [3](#T3){ref-type="table"}). In spite of the generally low fold changes, a good correspondence in terms of expression ratios or in the direction of change (up- or down-regulation), was obtained between the microarray and RT-qPCR results for most quantified genes, including Δ5 fad and Δ6 fad, FAS and heme oxygenase 1 (HOX) for the factor diet, and ApoB, LPP2 and AGPAT for the factor genotype (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). However, comparison of the microarray and RT-qPCR expression results show an inverse change in expression for GFPT1 and glutathione S-transferase A (GST) in response to diet, the latter only in the Fat group, and of EL between family groups, although only when feeding on FO (where the fold-change in the microarray was negligible). Nonetheless, a perfect match was not expected given that RT-qPCR primers were obtained either from published work (e.g., GST) or, when available, designed on well characterized sequences such as GenBank reference sequences or clusters on the gene index database for Atlantic salmon (ASGI), which do not necessarily match exactly the clone on the array. In fact, in the case of EL there is evidence that the microarray probe has high similarity with multiple EST\'s and hence is likely to have resulted in cross-hybridisation \[[@B12]\], while the reference sequence for GFPT1 and the clone in the microarray are only 93% identical in the aligned region.

###### 

Relative expression of genes assayed by RT-qPCR in liver of Atlantic salmon

             VO/FO       Lean/Fat                                                                
  ---------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  Δ5 fad     **3.95**    **0.001**   **2.04**    **0.002**   **-2.33**   **0.009**   -1.20       0.317
  Δ6 fad_a   **8.27**    **0.000**   **4.52**    **0.004**   **-1.85**   **0.049**   -1.02       0.942
  elovl5a    1.18        0.505       -1.03       0.817       -1.18       0.420       1.03        0.908
  elovl5b    1.57        0.184       1.05        0.758       -1.25       0.471       1.19        0.416
  elovl2     **2.35**    **0.025**   -1.04       0.841       -1.56       0.098       1.58        0.112
  FAS        **1.76**    **0.005**   **2.11**    **0.003**   **-1.72**   **0.001**   **-2.04**   **0.011**
  PPARα      **-2.22**   **0.000**   1.10        0.643       -1.16       0.358       **-2.86**   **0.001**
  PPARβ      -1.92       0.161       1.56        0.169       1.24        0.659       **-2.44**   **0.002**
  PPARγ      -1.10       0.828       -1.67       0.251       -2.00       0.214       -1.32       0.229
  SREBP-1    -1.16       0.761       **3.32**    **0.004**   1.82        0.332       **-2.13**   **0.022**
  GST        -1.18       0.412       **1.40**    **0.010**   1.29        0.210       **-1.28**   **0.028**
  HOX        -2.69       0.132       **-1.82**   **0.013**   1.83        0.271       1.24        0.120
  GFPT1      -1.33       0.244       -1.65       0.090       -1.18       0.619       1.05        0.783
  ApoB       1.40        0.443       1.84        0.152       -1.15       0.791       -1.52       0.076
  EL         **3.52**    **0.034**   **8.57**    **0.002**   1.38        0.494       -1.75       0.115
  LPP2       -1.33       0.506       -1.31       0.606       -1.22       0.754       -1.25       0.516
  AGPAT      1.40        0.375       **1.42**    **0.041**   -1.05       0.906       -1.07       0.574

Values are normalised (by *cofilin-2*) gene expression ratios between fish fed VO in relation to FO for each family group or of Lean fish in relation to the Fat group when fed either one of the diets. Values in bold are significantly different, at p \< 0.05 (REST 2008).

fad: fatty acyl desaturase (Δ5 and Δ6); elovl: elongase (three different transcripts); FAS: Fatty acid synthase; PPARs; peroxisome proliferator-activated receptors (three isoforms); SREBP-1: Sterol regulatory element binding protein-1; GST: glutathione S-transferase A; HOX: heme oxygenase 1; GFPT1: glutamine-fructose-6-phosphate transaminase 1; ApoB: apolipoprotein B; EL: endothelial lipase; LPP2: lipid phosphate phosphohydrolase 2; AGPAT: 1-acyl-sn-glycerol-3-phosphate acyltransferase.

In terms of regulation of gene expression by the factor diet, the qPCR results confirmed the significant up-regulation of Δ5 fad and Δ6 fad in fish fed VO, with a higher fold change being measured for Δ6 fad. In addition, the expression ratio was higher in the Lean family group than in Fat fish, as had also been indicated in the microarray analysis. Of the elongase genes, only elovl2 was significantly up-regulated by the VO diet, but just in the Lean family group. Furthermore, quantification of PPAR genes revealed that only PPARα was down-regulated significantly when salmon were fed the VO diet, but only in the Lean family group. On the other hand, expression of SREBP-1 was only significantly affected in Fat fish, being up-regulated in fish fed the VO diet. Other genes which were significantly and consistently regulated were FAS and EL (both up-regulated when VO replaced FO in the diet), while GST, HOX and AGPAT only showed significant regulation in Fat fish. Finally, comparison between the two family groups showed a significantly lower expression of Δ5 fad, Δ6 fad, PPARα, PPARβ, SREBP-1 and GST in the Lean group but only when fish were fed FO, in the case of fads, or when fed the VO diet, in the case of PPARs, SREBP-1 and GST. In addition, FAS was also significantly down-regulated in the Lean group, independent of diet.

Liver fatty acid composition
----------------------------

Fatty acid analysis of liver showed significant differences in all fatty acid classes related mostly to diet but also to genotype (except for total n-3 PUFA and total PUFA) (Table [4](#T4){ref-type="table"}). The percentage of total n-6 PUFA (reflecting mainly 18:2n-6) was significantly increased when VO replaced FO in the diet. Levels of total n-3 PUFA were, on the other hand, significantly higher in the FO treatments independent of genotype. For EPA and DHA there was a significant diet × genotype interaction, resulting from the fact that, when comparing Fat and Lean fish, higher levels of these LC-PUFA were found in the Fat family group when fed the FO diet but the inverse was observed when the same fish were fed the VO diet.

###### 

Liver fatty acid composition (percentage of total fatty acids) of Atlantic salmon Lean and Fat family groups fed diets containing either FO or VO

  Parameters        FO           VO           ANOVA                                           
  ----------------- ------------ ------------ ------------ ------------ ---------- ---------- --------
  Fatty acid                                                                                  
  Total saturated   25.8 ± 0.8   22.1 ± 1.5   19.1 ± 1.0   18.3 ± 1.0   \<0.0001   \<0.0001   0.0044
  Total monoenes    23.8 ± 1.3   31.1 ± 2.5   40.8 ± 3.3   39.0 ± 2.5   \<0.0001   0.0141     0.0002
  18:2n-6           2.9 ± 0.1    3.0 ± 0.3    10.1 ± 0.2   10.4 ± 0.2   \<0.0001   0.0317     ns
  18:3n-6           0.1 ± 0.1    0.1 ± 0.1    0.1 ± 0.1    0.1 ± 0.0    ns         ns         ns
  20:2n-6           0.5 ± 0.0    0.7 ± 0.0    1.6 ± 0.2    1.9 ± 0.1    \<0.0001   \<0.0001   ns
  20:3n-6           0.4 ± 0.0    0.4 ± 0.0    1.3 ± 0.1    1.4 ± 0.1    \<0.0001   ns         ns
  20:4n-6           2.2 ± 0.2    1.9 ± 0.2    1.2 ± 0.1    1.4 ± 0.1    \<0.0001   ns         0.0009
  22:5n-6           0.2 ± 0.0    0.2 ± 0.1    0.1 ± 0.0    0.1 ± 0.0    \<0.0001   ns         ns
  Total n-6 PUFA    6.3 ± 0.3    6.3 ± 0.4    14.4 ± 0.3   15.3 ± 0.3   \<0.0001   0.0031     0.0031
  18:3n-3           1.0 ± 0.0    1.1 ± 0.2    4.3 ± 0.2    4.7 ± 0.2    \<0.0001   0.0021     0.0466
  18:4n-3           0.4 ± 0.1    0.4 ± 0.1    0.3 ± 0.0    0.3 ± 0.1    0.0104     ns         ns
  20:3n-3           0.2 ± 0.0    0.3 ± 0.0    0.7 ± 0.1    0.7 ± 0.3    \<0.0001   ns         ns
  20:4n-3           1.6 ± 0.1    2.3 ± 0.3    1.1 ± 0.1    1.3 ± 0.1    \<0.0001   \<0.0001   0.0021
  20:5n-3           8.6 ± 0.3    8.2 ± 0.4    4.7 ± 0.4    5.2 ± 0.4    \<0.0001   ns         0.0085
  22:5n-3           3.6 ± 0.2    4.4 ± 0.3    1.9 ± 0.2    2.1 ± 0.1    \<0.0001   \<0.0001   0.0025
  22:6n-3           28.6 ± 1.0   23.7 ± 1.9   12.6 ± 1.5   13.1 ± 1.1   \<0.0001   0.0011     0.0002
  Total n-3 PUFA    44.1 ± 1.1   40.5 ± 1.5   25.7 ± 2.4   27.4 ± 1.4   \<0.0001   ns         0.0009
  Total PUFA        50.4 ± 1.2   46.8 ± 1.5   40.2 ± 2.6   42.8 ± 1.6   \<0.0001   ns         0.0004

Results are means ± SD (n = 6) and p-values of two-way ANOVA are presented for factors \'diet\', \'genotype\' and interaction between both factors. ns, not significantly different (p \> 0.05).

Discussion
==========

In the present study we analysed the effects of diets containing high levels of plant proteins and with complete replacement of FO by VO on the liver transcriptome of Atlantic salmon, which is the primary metabolic organ of fish, as well as the influence of genotype on these responses. Here we focus on the separate effects of diet and genotype given that interactions, indicating pathways that were differentially affected by diet depending on the genetic background of the fish, were discussed in detail previously \[[@B12]\].

A common methodological difficulty in this type of nutritional experiment is that effects are typically quite subtle although physiological and metabolic pathways can be impacted by even small fold changes in gene expression. This has been demonstrated by several studies \[[@B7],[@B9],[@B11]\] and by previously reported data from the present study showing that low fold changes in gene expression were associated with biochemical differences in tissue lipid class and apolipoprotein composition \[[@B12]\]. Furthermore, low fold changes observed in this study were generally corroborated by RT-qPCR, even if the low expression ratios meant that differences were not always significant. It should also be noted that a total match between the microarray and the RT-qPCR results is not expected due to the approach taken to design RT-qPCR primers on better annotated reference sequences rather than on less well characterized microarray clones. In view of the whole genome duplication event that occurred in salmonid fishes \[[@B13]\], transcriptomic and gene expression studies are often more challenging due to the presence of duplicated and highly similar genes whose transcripts might be differentially regulated, as observed previously for lipoprotein lipase \[[@B12]\]. Therefore, collectively, and in conjunction with previous studies, data obtained in the present microarray study enabled identification of pathways that may be differentially affected by both dietary oil composition and genetic background related to flesh adiposity.

Effects of diet on lipid metabolism
-----------------------------------

Within the list of genes affected by diet, those involved in fatty acyl desaturation were prominent, leading to the identification, through GO enrichment analysis, of several terms related to LC-PUFA biosynthetic and metabolic processes. The up-regulation of Δ5 fad and Δ6 fad in both family groups when dietary FO was replaced by VO was confirmed by RT-qPCR. Several studies have previously demonstrated up-regulation of genes involved in LC-PUFA biosynthesis in salmon when FO is replaced by VO \[[@B10],[@B14],[@B15]\]. RT-qPCR also confirmed previous work showing that elovl2 is responsive to dietary n-3 LC-PUFA levels \[[@B15]\], being the only elongase whose expression was up-regulated when FO was replaced by VO. However, a significant effect was only observed in the Lean family group. In addition, both microarray and RT-qPCR analyses indicated that the up-regulation of Δ5 fad and Δ6 fad showed a considerably higher fold-change in the Lean fish, due mainly to lower basal expression of fads in Lean salmon, compared to Fat, when fed FO. These results indicate that the activity of this biosynthetic pathway may be dependent on the genetics of the fish, with different family groups showing differences in the magnitude of response. The liver fatty acid composition revealed that differences in EPA and DHA levels between fish fed either diet were smaller in the Lean fish, due to higher n-3 LC-PUFA in fish fed VO and lower n-3 LC-PUFA in fish fed FO, compared to the equivalent treatments in the Fat group. In addition, intermediates in the biosynthetic pathway, such as 20:4n-3 and 22:5n-3, tended to be present at higher levels in the Lean family group, suggesting that differences observed in the levels of mRNA of LC-PUFA biosynthesis genes, which have been shown to correlate with the enzymatic activity of this pathway in salmon \[[@B16],[@B17]\], were reflected in biochemical composition.

Another lipid metabolism gene significantly affected by diet was FAS, which was up-regulated in both family groups when fed VO. A well demonstrated effect of dietary FO supplementation in mammals is hypotriglyceridemia, resulting from a coordinated effect of n-3 LC-PUFA in suppressing hepatic lipogenesis and enhancing fatty acid oxidation in liver and muscle \[[@B18]\]. Furthermore, this gene also appears to be regulated at a pre-translational level and hence changes in FAS transcription are likely to result in important effects in terms of enzyme activity \[[@B19]\]. Similar mechanisms are believed to operate in fish but, although reduced hepatic lipogenic activity modulated by LC-PUFA has been demonstrated *in vitro*\[[@B20]\], a direct relationship with dietary FO and VO has not always been clear *in vivo*\[[@B21],[@B22]\]. The regulation of FAS in response to FO replacement by VO did not show an interaction with the flesh leanness/fatness phenotype in this study, as might have been expected. This was because genotype also had a significant effect, with the Lean group having lower levels of FAS expression than the Fat fish, with a similar fold-change in both diets.

Regulation of lipid metabolism is complex and controlled by several transcription factors and nuclear receptors, including PPARs and SREBPs. SREBP-1c is a major regulator of lipogenesis in mammals \[[@B18]\]. Here we measured the expression of SREBP-1 as there is no evidence for the existence of alternatively spliced isoforms in salmon, and primers corresponded to an identical region in mammalian SREBP-1a and SREBP-1c \[[@B23]\]. Our results agree with Minghetti et al. \[[@B23]\], who showed SREBP-1 was increased by cholesterol and decreased by EPA and DHA supplementation in a salmon cell line, denoting a similar nutritional regulation to mammals \[[@B18]\]. However, there was a clear genetic effect as expression of SREBP-1 was 3-fold higher in Fat salmon fed VO, containing lower EPA, DHA and cholesterol, than in fish fed FO, whereas no regulation was observed in the Lean group.

PPARs have been less studied in fish than in mammals but present evidence suggests PPARα and PPARβ have similar ligands and functions to their mammalian homologues, while PPARγ may present some functional differences \[[@B24],[@B25]\]. LC-PUFA are well recognised enhancers of PPARα activity in fish, and while the response of PPARβ to LC-PUFA might be variable between fish species, an enhancement of activity in sea bass, plaice and sea bream \[[@B24]-[@B26]\] and of expression in Atlantic salmon \[[@B27]\] has been observed. In addition, and unlike rodents, PPARα and PPARβ have a similar pattern of expression in response to fasting and feeding in sea bream liver, indicating that they may be regulated similarly \[[@B25]\]. In the present study, PPARα was down-regulated when VO replaced FO but only in the Lean family group and, although not statistically significant, PPARβ showed a similar trend, suggesting similar transcriptional regulation of these nuclear receptors by dietary fatty acid composition. These results thus indicate that the genetic background of the fish might affect PPAR transcriptional responses to LC-PUFA. In contrast, no nutritional regulation was observed for PPARγ transcription in liver, in accordance with previous studies in fish, including salmon, and its predominant role in adipocytes \[[@B24],[@B28]\].

The hypotriglyceridemic effects of n-3 LC-PUFA in mammals involve activation of PPARα, leading to up-regulation of β-oxidation genes (including carnitine palmitoyltransferase I - CPT1 and acyl-CoA oxidase - ACO) and suppression of SREBP-1c transcription that down-regulates lipogenic enzymes \[[@B29],[@B30]\]. As previously reported, FAS expression was up-regulated in both family groups fed the VO diet but neither CPT1 nor ACO expression, was affected \[[@B12]\]. As elovl2 expression was only altered in the Lean fish and both Δ5 fad and Δ6 fad showed greater up-regulation in Lean salmon fed VO, we may speculate that PPARα (and potentially also PPARβ) expression may be involved in down-regulation of LC-PUFA biosynthesis. Paradoxically, fatty acyl desaturases are regulated by both SREBPs and PPARs in mammals \[[@B31]\]. In addition, PPARα agonists regulate the transcriptional activity of elongases in rat, although only elovl5 and not elovl2 \[[@B32]\]. However, in mammals, PPARα ligands induce the transcription of elongases and desaturases while we observed an up-regulation of elovl2 and a stronger stimulation of Δ5 fad and Δ6 fad transcription when PPARα expression was lower. In the rat and human Δ6 fad gene promoters, both PUFA and PPARα response regions have been identified which suppress and induce, respectively, Δ6 fad expression \[[@B33]\]. The molecular mechanisms of transcriptional regulation of these genes are complex and will require further investigation in salmon \[[@B34]\]. In contrast, target genes of SREBP-1 remain elusive and, although it may regulate FAS expression \[[@B23]\], this was only observed in Fat fish whereas, in the Lean group, another mechanism is required to explain up-regulation of FAS in VO-fed fish as expression of SREBP-1 was unaffected. Nonetheless, the action of SREBP-1 is under the regulation of liver X receptor (LXR) and these complex pathways have only recently started to be investigated in fish \[[@B23]\].

Another gene affected by diet was squalene epoxidase (SQLE), which was up-regulated by VO but only markedly in the Lean family group. This enzyme catalyses the first oxygenation step in sterol biosynthesis, a pathway identified earlier as presenting a diet **×**genotype interaction \[[@B12]\]. In contrast, cytochrome P450 reductase (CPR) was down-regulated in salmon fed VO, particularly in Lean fish. This enzyme has multiple roles as the electron donor for several oxygenase enzymes, such as cytochrome P450 (involved in drug and xenobiotic metabolism, and sterol and bile acid synthesis), HOX and cytochrome b5 (which supports both sterol and LC-PUFA biosynthesis pathways). In addition, it has key roles in the biosynthesis of several signalling factors and the regulation of oxidative response genes \[reviewed by \[[@B35]\]\]. CPR is transcriptionally regulated by PPARα in mouse and, given the comparable PPARα and CPR expression in Lean salmon fed VO, similar regulation likely occurs in salmon. However, changes in CPR expression can be related to several processes that were affected by FO replacement. Thus, CPR expression could be linked to changes in both cholesterol and LC-PUFA biosynthesis, both more marked in Lean fish, although this is unlikely because VO induced up-regulation of these pathways. A more likely association is with cell oxidant metabolism, also suggested by the microarray results as being possibly down-regulated in VO-fed fish. In particular, down-regulation of HOX in salmon fed VO, more marked for Lean fish correlating with CPR expression, might be an indication of this.

Effect of diet on carbohydrate and intermediate metabolism
----------------------------------------------------------

Within the metabolism genes that were identified by the microarray analysis as being significantly affected by dietary oil substitution, a few relate to carbohydrate metabolism, particularly glucose and intermediary metabolism. Given that similar effects were observed in previous salmonid studies, and that a few signal transduction genes present in the list of diet significant effects are also potentially implicated in these pathways, these results warrant further discussion, even if the observed fold changes were low. An association between lipid and carbohydrate metabolism in salmon is not surprising given that the pathways of lipogenesis, lipolysis, glycolysis, gluconeogenesis and pentose phosphate shunt are all interrelated in the regulation of body energy homeostasis. In mammals, the role of LC-PUFA as \"fuel partitioners\" involves both directing fatty acids away from anabolic and towards catabolic routes as well as enhancing glucose flux to glycogen, mediated by effects on SREBP-1 and transcription factors that regulate key genes of lipid metabolism and glycolysis \[[@B30]\]. Similar mechanisms may operate in fish but differences are likely given that carnivorous fish like salmon have low capacity to use carbohydrate and appear to show features of glucose intolerance \[[@B36],[@B37]\]. Nonetheless, dietary n-3/n-6 ratio has been shown to influence mRNA levels of the glucose transporter GLUT4 in Atlantic salmon muscle, with some reflection in plasma glucose \[[@B38]\]. In addition to a decreased hexokinase and phosphoenolpyruvate carboxykinase expression, complete replacement of FM and FO by vegetable alternatives in rainbow trout resulted in a slightly increased expression of glycerol kinase, as observed here \[[@B11]\]. This enzyme is at the intersection of lipid-carbohydrate metabolism and over-expression of this gene in human muscle and rat hepatoma cells resulted in higher TAG synthesis and up-regulation of the pentose phosphate pathway providing reducing power for lipogenesis \[[@B39]\]. Panserat et al. \[[@B11]\] hypothesised that the up-regulation of glycerol kinase may be related to higher lipid biosynthesis in liver when trout were fed plant-based diets. Similarly, our results, associated with the observed changes in FAS mRNA when VO replaced FO, suggest a possible relationship with lipogenesis. Also possibly related with this was the up-regulation of two different biotinidase clones with the potential to increase availability of substrates for FAS and/or gluconeogenesis in VO-fed fish. This gene, besides being involved in the regulation of gene expression, including genes of glucose metabolism, codes for an enzyme that recycles biotin, which is a co-factor for several carboxylases responsible for production of substrates for lipogenesis and gluconeogenesis \[[@B40]\].

Another gene affected by diet was alpha-enolase, which was slightly down regulated in Lean fish fed VO. A similar effect was observed in liver of salmon fed rapeseed oil in comparison to FO \[[@B9]\]. This glycolytic enzyme participates in the conversion of glucose to pyruvate, a key intermediate at the intersection of multiple metabolic pathways, including lipogenesis. Thus, this might result in lower levels of pyruvate for conversion to acetyl-CoA in VO-fed fish. This result does not necessarily conflict with an increase in lipogenesis given that, in fish, carbon skeletons for *de novo*fatty acid production are mainly derived from amino acid catabolism rather than from carbohydrates, whose main contribution towards lipogenesis is to supply NADPH via the pentose-phosphate pathway \[[@B37]\].

Finally, a few signalling genes that were significantly affected by diet might also have an effect on glucose metabolism, assuming that similar cascades exist in fish. One of these is phosphoinositide 3-protein kinase (PI3K), which mediates insulin\'s effects on glucose, lipid and protein metabolism, and that was significantly down regulated in VO-fed fish. Among other roles, it regulates glucose cellular uptake in mammals, recruiting GLUT4 transporters to the cell surface \[[@B41]\]. In addition, it is found upstream of a signal transduction cascade regulating glycogen synthesis through glycogen synthase, by inactivating glycogen synthase kinase-3 (GSK3) \[[@B41],[@B42]\]. In our study, expression of GSK3-binding protein (GBP) was significantly increased in VO-fed Lean fish. GBP is a protein that blocks GSK3, which in turn inactivates glycogen synthase \[[@B43]\]. Hence, it is possible that the oil composition of the diet might also affect glucose metabolism and glycogen storage.

Effect of diet on oxidative stress and immune response
------------------------------------------------------

Increased oxidative stress associated with the consumption of FO has been typically reported in fish and mammals \[[@B27],[@B44],[@B45]\]. Accordingly, genes related to oxidant metabolism were found in the significant list for diet. A thioredoxin domain-containing protein, possessing an antioxidant role \[[@B46]\], and GST, which detoxifies peroxidised lipids and xenobiotics \[[@B47]\], were down-regulated in salmon fed VO, consistent with the higher auto-oxidative potential of LC-PUFA in FO. However, quantification of GST by RT-qPCR was not consistent with the microarray result, although the possibility exists that different GST genes with differential regulation exist in salmon and this requires clarification. In addition, the observed down-regulation of HOX in VO-fed fish, validated by RT-qPCR, might be related to a decrease in oxidative stress in these fish. This enzyme catalyses the degradation of heme and can be induced by oxidative stress \[[@B48]\] and may be increased during pro-inflammatory states, being thought to increase resistance to oxidative injury and ameliorate inflammation \[[@B49]\]. The n-3 LC-PUFA in FO have important anti-inflammatory actions in mammals \[[@B50]\], which does not correlate with the expression of HOX and its putative role in inflammation in this case. Inflammation is an important mechanism in immune defence but, in fish, the demonstrated effects of LC-PUFA on immune and inflammatory mechanisms have been inconsistent \[[@B45]\]. However, a recent study has clearly shown an effect of dietary oil composition on the progression of a myxosporean parasite infection in Gilthead sea bream, with fish fed the VO diet showing higher signs of the disease and faster course of infection in comparison with those on a FO diet \[[@B51]\]. On the other hand, the synthesis of pro-inflammatory eicosanoids was increased in the intestine of salmon fed vegetable-based diets in response to acute stress \[[@B52]\]. In the present study immune response was the second highest category of genes affected by diet, after metabolism. Whether this is due to the potential anti-inflammatory role of dietary FO or whether VO diets can have detrimental health effects is not clear as the fold-changes were subtle, as expected in unchallenged animals. Nonetheless, the majority of genes related to processes of both innate and adaptive immunity were up-regulated in fish fed VO. Only T-cell and leukotriene B~4~(LTB~4~) receptors, that are reduced after antigen and LTB~4~exposure, respectively, and, in the case of LTB~4~receptor, increased after EPA administration \[[@B53]-[@B55]\], were down-regulated in salmon fed VO.

Differences in gene expression between Lean and Fat genotypes
-------------------------------------------------------------

Muscle adiposity is a trait of great importance in animal production, aquaculture included, and hence physiological changes induced by genetic selection for this phenotype have been examined in various animals, including rainbow trout \[[@B7],[@B8]\]. In the present study the main differences between family groups were associated with signal transduction pathways, followed by metabolism. Only a small number of lipid metabolism genes varied in relation to muscle adiposity, as reported previously in rainbow trout, where the main differences were related to lipogenesis and mitochondrial oxidative metabolism \[[@B7],[@B8]\]. In our study glycerophospholipid metabolism may have been down-regulated in the Lean family group through AGPAT and LPP2, two enzymes acting consecutively on *de novo*TAG and phospholipid biosynthesis \[[@B56],[@B57]\]. Quantification of AGPAT and LPP2 expression by RT-qPCR confirmed this down-regulation but fold-changes were too subtle to be significant. AGPAT converts lysophosphatidic acid into phosphatidic acid (PA), while LPP2 then catalyzes the conversion of PA to diacylglycerol. All these molecules can function as second messengers and are involved in the regulation of multiple signalling pathways. Therefore, down-regulation of this pathway in the Lean group has the potential to lower lipid biosynthesis, at least partly explaining the flesh lipid phenotype, but may also alter levels of lipid signalling molecules. On the other hand, differences in muscle adiposity might also be caused by higher hepatic \"de novo\" fatty acid synthesis in the Fat family group, as indicated by the expression of FAS. In a previous study, no differences were found in the expression of ACO and CPT1, which suggested that the phenotypes could not be explained by differences in β-oxidation \[[@B12]\]. By contrast, in rainbow trout Fat and Lean families, β-oxidation and mitochondrial oxidative metabolism, but not lipogenesis, were affected by genetic selection \[[@B7]\], although another study using the same trout lines suggested differences related to lipogenesis rather than fatty acid oxidation \[[@B8]\]. Thus, both metabolic processes are likely involved and discrepancies in the data are likely due to lack of methodological sensitivity to detect the small fold-changes that are possibly characteristic of these biological processes and typical in this type of experiment.

PPARα, PPARβ and SREBP-1 were also regulated in response to genotype, being down-regulated in Lean fish, but only when fed the VO diet. In cobia, *Rachycentron canadum*, a negative correlation was found between PPARα mRNA levels in liver and body lipid deposition \[[@B58]\]. Furthermore, PPARβ appears to play a similar role in fish to that in mammals, as a ubiquitous regulator of fat burning and with a role in energy mobilisation during early development \[[@B24],[@B25]\]. Therefore, both PPARα and PPARβ might have a role in the control of adipogenesis in fish and it may be the case that, similarly to chickens \[[@B59]\], Fat salmon might have higher lipid turnover than their Lean counterparts when fed a diet that predisposes for hepatic fat deposition, even though the end result is higher lipid accumulation in liver \[[@B60]\]. To explain this, Collin et al. \[[@B59]\] suggested that a fat chicken family is better \"equipped\" to deal with higher circulating levels of TAG when fed a high fat diet, compared to lean chicken. On the other hand, we observed a direct relationship between SREBP-1 and FAS expression in the Fat family group in response to diet, as well as in VO-fed fish in response to genotype. It thus appears that SREBP-1 may be partly responsible for higher lipogenesis in Fat fish, compared to Lean, when fed VO.

Conclusions
===========

This study has enabled the identification of metabolic pathways and key regulators that may respond differently to more sustainable diets, in which FO is replaced by VO, depending on genotype, thus confirming the potential of microarrays as hypothesis-generating tools, even in these nutritional studies where changes in gene expression are quite subtle. Collectively, and in conjunction with previous studies, the data indicate that dietary lipid composition may potentially affect glucose, glycogen storage and intermediary metabolism, in addition to lipogenesis, supporting a role for LC-PUFA in \"fuel partitioning\" in fish as well as in mammals. Therefore, more integrative studies investigating the effects of dietary VO on energy homeostasis are required. However, important genotype-related differences may also exist in the regulation of metabolism. In terms of lipid metabolism, expression of LC-PUFA and lipid biosynthesis genes, as well as of key regulator transcriptional factors, was differentially affected by diet depending on the genetic background of the fish. Although further studies are required, the present data indicate that it will be possible to identify families better adapted to alternative diet formulations that might be appropriate for future genetic selection programmes.

Methods
=======

Feeding trial and sampling
--------------------------

A dietary trial was conducted using two genetically characterised and contrasting groups of farmed Atlantic salmon post-smolts, comprising full-sib families selected from the Landcatch Natural Selection Ltd (LNS) breeding program (Argyll, Scotland). The choice of the two family groups was based on estimated breeding values (EBVs) of the parents for high or low flesh adiposity, assessed by Torry Fatmeter (Distell Industries, West Lothian, UK), a trait that was found to have a heritability ranging from 0.17 to 0.39 in this dataset. The two groups were created from four unrelated full-sib families; two families from the extreme lower end of the EBV distribution for flesh lipid content (\'Lean\') and two families from the extreme upper end of the distribution (\'Fat\'). The average EBV for the lipid content of the two Fat families was 2.00 percentage units higher than that of the two selected Lean families, representing a standardised selection differential of 2.33 standard deviations. Assessment of the flesh and viscera lipid content at the end of the feeding trial confirmed differences in adiposity between the two genotypes, in spite of an interaction with diet being also found \[[@B12]\].

Two thousand fish of each group were stocked into eight 12 × 5 m^3^net pens at the Ardnish Fish Trials Unit (Marine Harvest Scotland, Lochailort, Highland; 500 fish pen^-1^). Duplicate pens from each group of fish were fed one of two experimental diets (Skretting ARC, Stavanger, Norway) containing 32-25% fish meal, 40-45% plant meals and 27.5-30% oil supplied either as northern fish oil (FO) or as a vegetable oil (VO) blend comprising rapeseed, palm and *Camelina*oils in a ratio of 5:3:2 \[[@B12]\]. Diets were formulated to fully satisfy the nutritional requirements of salmonid fish \[[@B61]\] and contained similar levels of PUFA (around 31%) but different n-3 and n-6 PUFA contents, 25.3% and 4.6% in the FO diet and 13.4% and 17.1% in the VO diet, respectively. Further details including full diet formulations, proximate and fatty acid compositions of the feeds can be found in Bell et al. \[[@B60]\].

After 55 weeks on the experimental diets 25 fish were sampled per pen. The fish were killed by a blow to the head following anaesthesia using MS222, 24 h after the last meal. Samples of liver were immediately frozen on dry ice and stored at -70°C for molecular and fatty acid analyses.

RNA extraction and purification
-------------------------------

Liver tissue (0.2 g) from six individuals per experimental group was rapidly homogenised in 2 mL of TRI Reagent (Ambion, Applied Biosystems, Warrington, U.K.) using an Ultra-Turrax tissue disrupter (Fisher Scientific, Loughborough, U.K.) and stored at -70°C. Total RNA was later isolated, following manufacturer\'s instructions, and RNA quality (integrity and purity) and quantity was assessed by gel electrophoresis and spectrophotometry (NanoDrop ND-1000, Thermo Scientific, Wilmington, U.S.A.). One hundred micrograms of total RNA from each individual sample was further cleaned by mini spin-column purification (RNeasy Mini Kit, Qiagen, Crawley, UK), and then re-quantified and quality assessed as above.

Microarray hybridizations and image analysis
--------------------------------------------

The TRAITS/SGP (v.2.1) salmon 17 k cDNA microarray, described in detail by Taggart et al. \[[@B10]\], was used in this experiment (ArrayExpress accession: A-MEXP-1930). A dual-label experimental design was employed for the microarray hybridisations. Each experimental sample was competitively hybridised against a common pooled-reference sample, which comprised equal amounts of all samples used in the study. This design permits valid statistical comparisons across all treatments to be made. The entire experiment comprised 24 hybridisations - 2 genotypes (Lean/Fat) × 2 diets (FO/VO) × 6 biological replicates.

An indirect labelling methodology was employed in preparing the microarray targets. Antisense amplified RNA (aRNA) was produced from 500 ng of purified total RNA per sample using the Amino Allyl MessageAmpTM II aRNA Amplification Kit (Ambion, Applied Biosystems), as per manufacturer\'s instructions, followed by Cy3 or Cy5 fluor incorporation mediated by a dye-coupling reaction, as previously described in detail \[[@B12]\]. Experimental samples and the pooled reference sample (batch reaction) were labelled with Cy3 and Cy5 dye suspension stocks (PA23001 or PA25001, GE HealthCare, Little Chalfont, UK), respectively. Unincorporated dye was removed by column purification (Illustra AutoSeq G-50 spin columns; GE Healthcare). Dye incorporation and aRNA yield were quantified by spectrophotometry (NanoDrop ND-1000) and further quality controlled by separating 0.4 μL of the sample through a thin mini-agarose gel and visualising products on a fluorescence scanner (Typhoon Trio, GE Healthcare).

Microarray hybridisations were performed in a Lucidea semi-automated system (GE Healthcare), without a pre-hybridisation step. For hybridisation of each array, each labelled biological replicate and corresponding pooled reference (40 pmol each dye, c. 150 ng aRNA) were combined and added to the hybridisation solution, comprising 185 μL 0.7X UltraHyb buffer (Ambion), 20 μL poly(A) at l0 mg/mL (Sigma-Aldrich, Dorset, UK), 10 μL herring sperm at c. 10 mg/mL (Sigma-Aldrich) and 10 μL ultra pure BSA at 10 mg/mL (Sigma-Aldrich), as detailed previously \[[@B12]\]. Two post-hybridisation automatic washes followed by six manual washes to a final stringency of 0.1× SSC (EasyDipTM Slide staining system; Canemco Inc., Quebec, Canada) were performed before scanning.

Scanning was performed at 10 μm resolution using an Axon GenePix 4200AL Scanner (MDS Analytical Technologies, Wokingham, Berkshire, U.K.) with laser power constant (80%) and \"auto PMT\" enabled to adjust PMT for each channel such that less than 0.1% of features were saturated and that the mean intensity ratio of the Cy3 and Cy5 signals was close to one. BlueFuse software (BlueGnome, Cambridge, U.K.) was then used to identify features and extract fluorescence intensity values from the resultant TIF images. Following a manual spot removal procedure and fusion of duplicate spot data (BlueFuse proprietary algorithm), the resulting fluorescence intensity data and quality annotations for the 17,102 gene features, were exported into the GeneSpring GX version 10.0.2 analysis platform (Agilent Technologies, Wokingham, Berkshire, U.K.) after undergoing a block Lowess normalisation. Data transformation and quality filtering were then performed and all control features were excluded from subsequent analyses \[[@B12]\]. This returned a list of 14,772 genes eligible for statistical analysis. Experimental annotation complied fully with minimum information about a microarray experiment (MIAME) guidelines \[[@B62]\]. The experimental hybridisations and further methodological details are archived on the EBI ArrayExpress database (<http://www.ebi.ac.uk/arrayexpress/>) under accession number E-TABM-1089.

RT-qPCR
-------

Expression of selected genes was determined by reverse transcription quantitative real time PCR (RT-qPCR). Details on the target qPCR primer sequences are given in Table [5](#T5){ref-type="table"}. In addition, amplification of three potential reference genes - *cofilin-2*, elongation factor-1α (*elf-1α*) and *β-actin*- was performed. However, only *cofilin-2*expression proved to be sufficiently stable across treatments for normalisation of the results. *Cofilin-2*had been established in a previous salmon cDNA microarray study as a suitable reference gene on the basis of constant expression between FO and VO based feeds over a wide range of time points (\'unidentified liver EST\', \[[@B10]\]).

###### 

Primers used for RT-qPCR analyses

  Transcript         Primer sequence (5\'-3\')     Fragment   Ta     Efficiency   Accession No.      Source
  ------------------ ----------------------------- ---------- ------ ------------ ------------------ ------------
  Δ5fad              GTGAATGGGGATCCATAGCA          192 bp     56°C   0.995        AF478472 ^1^       \[[@B66]\]
                     AAACGAACGGACAACCAGA                                                             
  Δ6fad_a            CCCCAGACGTTTGTGTCAG           181 bp     56°C   0.944        AY458652 ^1^       \[[@B66]\]
                     CCTGGATTGTTGCTTTGGAT                                                            
  elovl5a            ACAAGACAGGAATCTCTTTCAGATTAA   137 bp     60°C   0.925        AY170327 ^1^       \[[@B15]\]
                     TCTGGGGTTACTGTGCTATAGTGTAC                                                      
  elovl5b            ACAAAAAGCCATGTTTATCTGAAAGA    141 bp     60°C   0.940        DW546112 ^1^       \[[@B15]\]
                     CACAGCCCCAGAGACCCACTT                                                           
  elovl2             CGGGTACAAAATGTGCTGGT          145 bp     60°C   0.960        TC91192 ^2^        \[[@B15]\]
                     TCTGTTTGCCGATAGCCATT                                                            
  FAS                GTGCCCACTGAATACCATCC          212 bp     60°C   0.995        CK876943 ^1^       New design
                     ATGAACCATTAGGCGGACAG                                                            
  PPARα              TCCTGGTGGCCTACGGATC           111 bp     60°C   0.986        DQ294237 ^1^       \[[@B67]\]
                     CGTTGAATTTCATGGCGAACT                                                           
  PPARβ              GAGACGGTCAGGGAGCTCAC          151 bp     60°C   0.992        AJ416953 ^1^       \[[@B67]\]
                     CCAGCAACCCGTCCTTGTT                                                             
  PPARγ              CATTGTCAGCCTGTCCAGAC          144 bp     60°C   0.999        AJ416951 ^1^       \[[@B67]\]
                     TTGCAGCCCTCACAGACATG                                                            
  SREBP-1            GCCATGCGCAGGTTGTTTCTTCA       151 bp     63°C   0.942        TC148424 ^2^       \[[@B20]\]
                     TCTGGCCAGGACGCATCTCACACT                                                        
  GST                ATTTTGGGACGGGCTGACA           81 bp      60°C   0.989        GE619558 ^1^       \[[@B68]\]
                     CCTGGTGCTCTGCTCCAGTT                                                            
  HOX                GTCAACGCATCACCCTTCTT          206 bp     60°C   0.997        BT046987 ^1^       New design
                     ATGGGGTCCTTCATCCTCTT                                                            
  GFPT1              GTGGTTTGGCAGACCTCCTA          177 bp     60°C   0.999        NM_001140266 ^1^   New design
                     TGTACGGTGCCATCTTTCAA                                                            
  ApoB               AGCCTTCGATGCTGTCGGCCA         153 bp     60°C   1.000        TC79364 ^2^        \[[@B12]\]
                     AGGAGCACAGGCAGGGTGGTT                                                           
  EL                 CCGGTGCTGCTGGAGGAAGC          378 bp     60°C   0.962        NM_001140535 ^1^   \[[@B12]\]
                     CGACATGCAGGTCATCGGT                                                             
  LPP2               TCCGGAAGAACTCGCAATAC          174 bp     60°C   0.949        NM_001140716 ^1^   New design
                     ACATCACGTCCACCAAGACA                                                            
  AGPAT              GAGAGCCAGAGGTTGAGGTG          245 bp     60°C   0.941        NM_001141753 ^1^   New design
                     CAGAGTGAAGGCGATGTGAA                                                            
                                                                                                     
  Reference genes:                                                                                   
  elf-1α             CTGCCCCTCCAGGACGTTTACAA       175 bp     60°C   0.986        AF321836 ^1^       \[[@B15]\]
                     CACCGGGCATAGCCGATTCC                                                            
  β-actin            ACATCAAGGAGAAGCTGTGC          141 bp     56°C   0.968        AF012125 ^1^       \[[@B15]\]
                     GACAACGGAACCTCTCGTTA                                                            
  Cofilin-2          AGCCTATGACCAACCCACTG          224 bp     60°C   0.999        TC63899 ^2^        \[[@B15]\]
                     TGTTCACAGCTCGTTTACCG                                                            

^1^GenBank (<http://www.ncbi.nlm.nih.gov/>)

^2^Atlantic salmon Gene Index (<http://compbio.dfci.harvard.edu/tgi/>)

For RT-qPCR, 1 μg of column-purified total RNA per sample was reverse transcribed into cDNA using the VersoTM cDNA kit (ABgene, Surrey, U.K.), following manufacturer\'s instructions, using a mixture of random hexamers (400 ng/μL) and anchored oligo-dT (500 ng/μL) at 3:1 (v/v). Negative controls (containing no enzyme) were performed to check for genomic DNA contamination. A similar amount of cDNA was pooled from all samples and the remaining cDNA was then diluted 20-fold with water. RT-qPCR analysis used relative quantification with the amplification efficiency of the primer pairs being assessed by serial dilutions of the cDNA pool. qPCR amplifications were carried out in duplicate (Quantica, Techne, Cambridge, U.K.) in a final volume of 20 μL containing either 5 μL or 2 μL (for the reference genes and HOX) diluted (1/20) cDNA, 0.5 μM of each primer and 10 μL AbsoluteTM QPCR SYBR^®^Green mix (ABgene). Amplifications were carried out with a systematic negative control (NTC-non template control). The qPCR profiles contained an initial activation step at 95°C for 15 min, followed by 30 to 40 cycles (depending on target): 15 s at 95°C, 15 s at the specific primer pair annealing temperature (Ta; Table [5](#T5){ref-type="table"}) and 15 s at 72°C. After the amplification phase, a melt curve of 0.5°C increments from 75°C to 90°C was performed, enabling confirmation of the amplification of a single product in each reaction. RT-qPCR product sizes were checked by agarose gel electrophoresis and the identity of amplicons of newly designed primers (FAS, GFPT1, HOX, LPP2 and AGPAT) was confirmed by sequencing.

Lipid extraction and fatty acid analyses
----------------------------------------

Total lipids from six fish per treatment were extracted and determined gravimetrically from 1-2 g of liver by Ultra Turrax homogenisation in 20 volumes of chloroform/methanol (2:1 v/v) \[[@B63]\]. Fatty acid methyl esters (FAME) were prepared by acid-catalysed transesterification of total lipids \[[@B64]\]. Following purification, FAME were separated and quantified by gas-liquid chromatography using a Thermo Fisher Trace GC 2000 (Thermo Fisher, Hemel Hempstead, UK) equipped with a fused silica capillary column (ZB wax, 30 m×0.32 mmi.d.; Phenomenex, Macclesfield, UK) with hydrogen as carrier gas and using on-column injection. The temperature gradient was from 50 to 150°C at 40°C/min and then to 195°C at 1.5°C/min and finally to 220°C at 2°C/min. Individual methyl esters were identified by comparison with known standards. Data were collected and processed using the Chromcard for Windows (version 2.00) computer package (Thermoquest Italia S.p.A., Milan, Italy).

Statistical analysis
--------------------

Microarray hybridisation data were analysed in GeneSpring GX version 10.0.2 (Agilent Technologies) by two-way ANOVA, which examined the explanatory power of the variables \'diet\' and \'genotype\' (diet×genotype interaction presented in \[[@B12]\]), followed by Gene Ontology (GO) enrichment analysis, at a significance level of 0.05. No multiple test correction was employed as previous analyses, confirmed by RT-qPCR, indicate that such corrections are over-conservative for this type of data \[[@B14]\]. Gene expression results assessed by RT-qPCR were analysed by the ΔΔCt method using the relative expression software tool (REST 2008, <http://www.gene-quantification.info/>), employing a pair wise fixed reallocation randomisation test (10,000 randomisations) with efficiency correction \[[@B65]\], to determine the statistical significance of expression ratios between two treatments. Finally, significant differences in liver fatty acid composition were determined by means of two-way ANOVA, at a significance level of p \< 0.05, using the Graphpad Prism™ (version 4.0) statistical package (Graphpad Software, San Diego, CA).
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